{"result": {"id": "cf724db0-a65f-4825-963e-f8f1fa3f376f", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>IMPACT<|>EVENT<|>Intervention for High-Normal Blood Pressure in Type 2 Diabetes: A Randomized Controlled Trial (IMPACT) is a study investigating whether blood pressure lowering treatment should be initiated earlier in diabetic patients)\n##\n(\"entity\"<|>首都医科大学附属北京安贞医院<|>ORGANIZATION<|>Beijing Anzhen Hospital, Capital Medical University where Wu Zhaosu is affiliated)\n##\n(\"entity\"<|>上海交通大学医学院附属瑞金医院<|>ORGANIZATION<|>Ruijin Hospital, Shanghai Jiao Tong University School of Medicine where Wang Jiguang and Chen Xin are affiliated)\n##\n(\"entity\"<|>广东省人民医院<|>ORGANIZATION<|>Guangdong Provincial People's Hospital where Chen Luyuan and Cai Anping are affiliated)\n##\n(\"entity\"<|>新疆维吾尔自治区人民医院<|>ORGANIZATION<|>Xinjiang Uygur Autonomous Region People's Hospital where Li Nanfang is affiliated)\n##\n(\"entity\"<|>福建医科大学附属第一医院<|>ORGANIZATION<|>The First Affiliated Hospital of Fujian Medical University where Lin Jinxiu is affiliated)\n##\n(\"entity\"<|>北京大学人民医院<|>ORGANIZATION<|>Peking University People's Hospital where Sun Ningling and Liu Jing are affiliated)\n##\n(\"entity\"<|>陆军军医大学大坪医院<|>ORGANIZATION<|>Daping Hospital, Army Medical University where Zhu Zhiming is affiliated)\n##\n(\"entity\"<|>中国医学科学院阜外医院<|>ORGANIZATION<|>Fuwai Hospital, Chinese Academy of Medical Sciences where Zhang Yuqing is affiliated)\n##\n(\"entity\"<|>清华大学附属北京清华长庚医院<|>ORGANIZATION<|>Beijing Tsinghua Changgung Hospital, Tsinghua University where Ma Zhiyi is affiliated)\n##\n(\"entity\"<|>大连医科大学附属第一医院<|>ORGANIZATION<|>The First Affiliated Hospital of Dalian Medical University where Song Wei is affiliated)\n##\n(\"entity\"<|>西安交通大学第一附属医院<|>ORGANIZATION<|>The First Affiliated Hospital of Xi'an Jiaotong University where Wang Yang is affiliated)\n##\n(\"relationship\"<|>吴兆苏<|>首都医科大学附属北京安贞医院<|>Wu Zhaosu is affiliated with Beijing Anzhen Hospital, Capital Medical University<|>8)\n##\n(\"relationship\"<|>王继光<|>上海交通大学医学院附属瑞金医院<|>Wang Jiguang is affiliated with Ruijin Hospital, Shanghai Jiao Tong University School of Medicine<|>8)\n##\n(\"relationship\"<|>陈鲁原<|>广东省人民医院<|>Chen Luyuan is affiliated with Guangdong Provincial People's Hospital<|>8)\n##\n(\"relationship\"<|>李南方<|>新疆维吾尔自治区人民医院<|>Li Nanfang is affiliated with Xinjiang Uygur Autonomous Region People's Hospital<|>8)\n##\n(\"relationship\"<|>林金秀<|>福建医科大学附属第一医院<|>Lin Jinxiu is affiliated with The First Affiliated Hospital of Fujian Medical University<|>8)\n##\n(\"relationship\"<|>孙宁玲<|>北京大学人民医院<|>Sun Ningling is affiliated with Peking University People's Hospital<|>8)\n##\n(\"relationship\"<|>祝之明<|>陆军军医大学大坪医院<|>Zhu Zhiming is affiliated with Daping Hospital, Army Medical University<|>8)\n##\n(\"relationship\"<|>张宇清<|>中国医学科学院阜外医院<|>Zhang Yuqing is affiliated with Fuwai Hospital, Chinese Academy of Medical Sciences<|>8)\n##\n(\"relationship\"<|>刘靖<|>北京大学人民医院<|>Liu Jing is affiliated with Peking University People's Hospital<|>8)\n##\n(\"relationship\"<|>蔡安平<|>广东省人民医院<|>Cai Anping is affiliated with Guangdong Provincial People's Hospital<|>8)\n##\n(\"relationship\"<|>陈歆<|>上海交通大学医学院附属瑞金医院<|>Chen Xin is affiliated with Ruijin Hospital, Shanghai Jiao Tong University School of Medicine<|>8)\n##\n(\"relationship\"<|>马志毅<|>清华大学附属北京清华长庚医院<|>Ma Zhiyi is affiliated with Beijing Tsinghua Changgung Hospital, Tsinghua University<|>8)\n##\n(\"relationship\"<|>宋玮<|>大连医科大学附属第一医院<|>Song Wei is affiliated with The First Affiliated Hospital of Dalian Medical University<|>8)\n##\n(\"relationship\"<|>汪洋<|>西安交通大学第一附属医院<|>Wang Yang is affiliated with The First Affiliated Hospital of Xi'an Jiaotong University<|>8)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558899, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 1060, "prompt_tokens": 3936, "total_tokens": 4996, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3840}, "prompt_cache_hit_tokens": 3840, "prompt_cache_miss_tokens": 96}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: �压正常高值合并 2型糖尿病人群降  压干预研究(intervention forhigh-normalblood pres- surein type2 diabetes:arandomized controlled trial,  IMPACT)将明确糖尿病患者的降压时机是否应该  提前。\n　　　(4)进一步明确 ABPM 和 HBPM 起始治疗的血 压阈值和降压目标值。\n(5)生命不同阶段的最佳收缩压和舒张压水平。\n(6)心血管风险评估是否应考虑短期 BPV和长期\n\n\nBPV?\n　　　(7)如何实现和评估血压持续、长久达标?  以及哪 些治疗方案更有助于改善长期 BPV 和 TTR并带来 更多心血管获益?\n　　　(8)儿童和青少年的血压水平与心血管和肾脏结 局之间的相关性。\n　　(9)一生中的血压轨迹和高血压表型与心血管和 肾脏结局的相关性。\n(10)药物治疗降低夜间血压对临床结局的影响。\n　　　(11) 降压治疗对白大衣性高血压和隐蔽性高血压 患者临床结局的影响。\n　　　(12) 真正难治性高血压药物治疗对心血管和肾脏 事件的影响。\n(13)RDN对心血管和肾脏结局的影响。\n(14)无袖带血压测量设备的有效性及应用。\n　　　(15)如何有效评估治疗依从性 , 以及如何干预以 改善依从性。\n\n\n中国高血压防治指南(2024年修订版)修订委员会\n\n\n名誉主任委员\n　吴兆苏(首都医科大学附属北京安贞医院) 主任委员\n王继光(上海交通大学医学院附属瑞金医院) 副主任委员\n陈鲁原(广东省人民医院)\n　李南方(新疆维吾尔自 治区人民医院) 林金秀(福建医科大学附属第一医院) 孙宁玲(北京大学人民医院)\n祝之明(陆军军医大学大坪医院) 秘书长\n　张宇清(中国医学科学院阜外医院) 刘   靖(北京大学人民医院)\n学术秘书\n蔡安平(广东省人民医院)\n　陈   歆(上海交通大学医学院附属瑞金医院) 马志毅(清华大学附属北京清华长庚医院)\n　宋   玮(大连医科大学附属第一医院) 汪    洋(西安交通大学第一附属医院) 撰稿委员会(按姓氏汉语拼音排序)\n　包玉倩(上海交通大学医学院附属第六人民医院) 蔡安平(广东省人民医院)\n陈鲁原(广东省人民医院)\n陈伟伟(国家心血管病中心)\n　陈   歆(上海交通大学医学院附属瑞金医院) 初少莉(上海交通大学医学院附属瑞金医院) 崔兆强(复旦大学附属中山医院)\n丁荣晶(中国医学科学院北京协和医院)\n\n\n　董虹孛(国家儿童医学中心 ,首都医科大学附属北京儿童医院) 杜雪平(首都医科大学�\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>中国高血压防治指南(2024年修订版)修订委员会<|>ORGANIZATION<|>Committee responsible for revising the Chinese hypertension prevention and treatment guidelines in 2024)\n##\n(\"entity\"<|>吴兆苏<|>PERSON<|>Honorary Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with Beijing Anzhen Hospital, Capital Medical University)\n##\n(\"entity\"<|>王继光<|>PERSON<|>Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with Ruijin Hospital, Shanghai Jiao Tong University School of Medicine)\n##\n(\"entity\"<|>陈鲁原<|>PERSON<|>Deputy Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with Guangdong Provincial People's Hospital)\n##\n(\"entity\"<|>李南方<|>PERSON<|>Deputy Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with Xinjiang Uygur Autonomous Region People's Hospital)\n##\n(\"entity\"<|>林金秀<|>PERSON<|>Deputy Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with The First Affiliated Hospital of Fujian Medical University)\n##\n(\"entity\"<|>孙宁玲<|>PERSON<|>Deputy Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with Peking University People's Hospital)\n##\n(\"entity\"<|>祝之明<|>PERSON<|>Deputy Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with Daping Hospital, Army Medical University)\n##\n(\"entity\"<|>张宇清<|>PERSON<|>Secretary-General of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with Fuwai Hospital, Chinese Academy of Medical Sciences)\n##\n(\"entity\"<|>刘靖<|>PERSON<|>Secretary-General of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with Peking University People's Hospital)\n##\n(\"entity\"<|>蔡安平<|>PERSON<|>Academic Secretary of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with Guangdong Provincial People's Hospital)\n##\n(\"entity\"<|>陈歆<|>PERSON<|>Academic Secretary of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with Ruijin Hospital, Shanghai Jiao Tong University School of Medicine)\n##\n(\"entity\"<|>马志毅<|>PERSON<|>Academic Secretary of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with Beijing Tsinghua Changgung Hospital, Tsinghua University)\n##\n(\"entity\"<|>宋玮<|>PERSON<|>Academic Secretary of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with The First Affiliated Hospital of Dalian Medical University)\n##\n(\"entity\"<|>汪洋<|>PERSON<|>Academic Secretary of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee, affiliated with The First Affiliated Hospital of Xi'an Jiaotong University)\n##\n(\"relationship\"<|>吴兆苏<|>中国高血压防治指南(2024年修订版)修订委员会<|>吴兆苏 is the Honorary Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>9)\n##\n(\"relationship\"<|>王继光<|>中国高血压防治指南(2024年修订版)修订委员会<|>王继光 is the Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>9)\n##\n(\"relationship\"<|>陈鲁原<|>中国高血压防治指南(2024年修订版)修订委员会<|>陈鲁原 is a Deputy Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>8)\n##\n(\"relationship\"<|>李南方<|>中国高血压防治指南(2024年修订版)修订委员会<|>李南方 is a Deputy Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>8)\n##\n(\"relationship\"<|>林金秀<|>中国高血压防治指南(2024年修订版)修订委员会<|>林金秀 is a Deputy Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>8)\n##\n(\"relationship\"<|>孙宁玲<|>中国高血压防治指南(2024年修订版)修订委员会<|>孙宁玲 is a Deputy Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>8)\n##\n(\"relationship\"<|>祝之明<|>中国高血压防治指南(2024年修订版)修订委员会<|>祝之明 is a Deputy Director of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>8)\n##\n(\"relationship\"<|>张宇清<|>中国高血压防治指南(2024年修订版)修订委员会<|>张宇清 is the Secretary-General of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>8)\n##\n(\"relationship\"<|>刘靖<|>中国高血压防治指南(2024年修订版)修订委员会<|>刘靖 is the Secretary-General of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>8)\n##\n(\"relationship\"<|>蔡安平<|>中国高血压防治指南(2024年修订版)修订委员会<|>蔡安平 is an Academic Secretary of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>7)\n##\n(\"relationship\"<|>陈歆<|>中国高血压防治指南(2024年修订版)修订委员会<|>陈歆 is an Academic Secretary of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>7)\n##\n(\"relationship\"<|>马志毅<|>中国高血压防治指南(2024年修订版)修订委员会<|>马志毅 is an Academic Secretary of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>7)\n##\n(\"relationship\"<|>宋玮<|>中国高血压防治指南(2024年修订版)修订委员会<|>宋玮 is an Academic Secretary of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>7)\n##\n(\"relationship\"<|>汪洋<|>中国高血压防治指南(2024年修订版)修订委员会<|>汪洋 is an Academic Secretary of the Chinese Hypertension Prevention and Treatment Guidelines (2024 Revision) Revision Committee<|>7)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_a00063d7ece5a105666dd99d009ac4396203817f3d5c74c86e3bdd8a0a9280d1_v2"}